# Validation of HyperDetector for SARS-CoV-2

> **NCT05124496** · — · SUSPENDED · sponsor: **HyperSpectral APD** · enrollment: 10000 (estimated)

## Conditions studied

- SARS-COV2 Infection

## Interventions

- **DEVICE:** Screening Device

## Key facts

- **NCT ID:** NCT05124496
- **Lead sponsor:** HyperSpectral APD
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-12-11
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Why stopped:** Collected sufficient samples for analysis
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124496, "Validation of HyperDetector for SARS-CoV-2". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05124496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*